Marsh heads into its third-quarter report with a story that has two very different halves. Last quarter, consolidated underlying growth accelerated to 5% from 4%, consulting surged and the company raised its capital return plans. Underneath those headlines, though, the insurance pricing cycle kept getting worse. Guy Carpenter slipped into negative territory and Mercer Health cooled sharply. The October 15 release, due before the opening bell, should show which half is winning.
Wall Street is looking for earnings of $1.96 per share on revenue of about $6.63 billion. Both figures sit well below the $2.96 and $7.40 billion posted in the second quarter. That gap mostly reflects normal seasonality, since the third quarter is typically Marsh's lightest, and it is not a sign of deterioration. Management did not offer a fresh numerical outlook, but it reaffirmed its full-year framework for the second straight quarter. That framework calls for underlying growth similar to last year, a 19th consecutive year of margin expansion and solid EPS growth. The more useful question is whether third-quarter results keep that plan on track, especially because management said more of this year's margin improvement would land in the fourth quarter. Adjusted margin fell to 29.3% in the second quarter from 31.8% in the first as investment spending ran ahead of revenue. A third quarter that shows spending beginning to level off would make the back-end-loaded margin promise more believable.
The central swing factor is pricing. Property catastrophe reinsurance rates fell about 16% at mid-year, the steepest decline in a quarter century. Global primary property rates dropped 12%, and overall commercial rates slid 6%. Guy Carpenter absorbed roughly six points of rate headwind on its way to a 2% underlying decline, and the mid-year renewals that drove that hit continue to flow through. If reinsurance stabilizes near flat, the bulls can argue the worst is in the numbers. A deeper decline would suggest consolidation among reinsurance buyers is compounding the rate problem. On the primary side, Marsh Risk US and Canada improved to 4% growth on double-digit new business, helped by data center and transactional risk work. Holding that pace while rates keep falling would be strong evidence that new business can outrun the soft market.
The other businesses carry their own tests. Marsh Management Consulting grew 13% last quarter, but management guided to mid-to-high single digits for the third quarter, partly because Middle East sales slowed. Landing inside that range would count as delivering on plan, not as a disappointment. Mercer Health's drop to 3% growth, its first sub-4% print in years, needs to look like a one-quarter retention blip rather than a new trend. Mercer Wealth, helped by assets under management climbing to $846 billion, should offer some cushion. The accelerated move of Guy Carpenter and Mercer under the single Marsh brand in September also deserves attention for any sign of disruption or added cost.
The market has been unforgiving. Shares have fallen 7% since the last report while the S&P 500 gained about 4%. At $173.66, the stock sits just below its 200-day moving average and much closer to its post-earnings low of $166.48 than its high near $198. Sentiment has shifted modestly from slightly bearish to mildly bullish, so expectations look restrained, not euphoric.
In the end, this report comes down to one question. Can growth in consulting, wealth and primary brokerage new business keep offsetting a historic reinsurance downturn while margins head toward the promised expansion? If Marsh reaffirms its full-year view with stable Guy Carpenter trends, the discounted share price leaves room for relief. If the soft market shows signs of spreading further into the results, the stock's underperformance may prove to have been an early warning.